MedTrace Logo

Circulating Tumor DNA Study in Patients With Endometrial Cancer

NCT05955079 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-07-21

No results posted yet for this study

Summary

The objective of this study is to identify a population at risk of early recurrence after oncologic resection surgery of a primary uterine tumor based on the detection of ctDNA

Conditions

Interventions

OTHER

Whole blood

3 samples (before, after surgery and before chemotherapy)

Sponsors & Collaborators

  • CARPEM, Institut du Cancer Paris

    collaborator UNKNOWN

  • Centre de recherche des Cordeliers

    collaborator UNKNOWN

  • METHYS DX

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Bruno BORGHESE, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Jérôme ALEXANDRE, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-10-31
Completion
2026-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05955079 on ClinicalTrials.gov